oral semaglutide dose for obesity weight loss dosage chart in units Oral semaglutide 50 mg taken

Most Americans believe being healthy and fit is one of the current status symbols particularly shared by Millennials

New trial data for Amgen's GLP-1 drug MariTide shows a weight loss of 20 percent in non-diabetic participants with obesity or overweight.

Blend into smoothies or add into yogurt, oatmeal, salads and more

A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial

The first biosimilar formulation of a GLP-1 receptor agonist, liraglutide, has recently been marketed, at a lower acquisition cost than the original formulation, whilst oral semaglutide remains the only currently available GLP-1 receptor agonist that is administered orally

New content online: The role of GLP1 receptor agonists in adult-onset type 1 diabetes mellitus